Literature DB >> 22167321

Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NFκB pathway.

Miljana Tanic1, Magdalena Zajac, Gonzalo Gómez-López, Javier Benítez, Beatriz Martínez-Delgado.   

Abstract

Microarray-based techniques are being useful to obtain miRNA and gene expression signatures associated with different tumors. BRCA1 deregulation is a frequent event in the pathogenesis of breast as well as other cancers. In addition to DNA repair functions of BRCA1, it is involved in a wide range of cellular processes such as cell cycle, chromatin remodeling or transcription. However, the molecular events underlying BRCA1-associated tumorigenesis are still largely unknown. In order to deepen our understanding of BRCA1-associated tumorigenesis, we integrated data from mRNA and miRNA microarray experiments on HCC1937 breast cancer cell line, and the isogenic HCC1937 stably expressing BRCA1, to obtain significant miRNA-mRNA relationships associated with the presence of BRCA1 gene. By using bioinformatic integration of gene and miRNA expression data, we found significant miRNA-gene relationships underlying the array signatures. We additionally evaluated the role of these statistically significant pairs at the biological pathways level and identified MAPK and NF-κB pathways associated with these expression changes. Furthermore, we experimentally validated miRNAs induced by BRCA1 that commonly regulate TRAF2, a key regulator of NF-κB and MAPK pathways. We demonstrate that miR-146a, miR-99b and miR-205, induced in HCC1937 BRCA1-expressing cells, bind and regulate TRAF2 gene. In addition, re-expression of miR-146a, miR-99b or miR-205 in HCC1937 BRCA1-null cells was sufficient to modulate NF-κB activity. Our results demonstrate that integration of mRNA and miRNA associated with BRCA1 expression was useful to discover new miRNA-gene interactions as molecular events underlying BRCA1-mediated tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22167321     DOI: 10.1007/s10549-011-1905-4

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  17 in total

Review 1.  BRCA1 and microRNAs: emerging networks and potential therapeutic targets.

Authors:  Suhwan Chang; Shyam K Sharan
Journal:  Mol Cells       Date:  2012-07-24       Impact factor: 5.034

2.  miR-10b, miR-26a, miR-146a And miR-153 Expression in Triple Negative Vs Non Triple Negative Breast Cancer: Potential Biomarkers.

Authors:  Insaf Fkih M'hamed; Maud Privat; Mounir Trimeche; Frédérique Penault-Llorca; Yves-Jean Bignon; Abderraouf Kenani
Journal:  Pathol Oncol Res       Date:  2017-01-18       Impact factor: 3.201

3.  BRCA1 regulation of epidermal growth factor receptor (EGFR) expression in human breast cancer cells involves microRNA-146a and is critical for its tumor suppressor function.

Authors:  E Kumaraswamy; K L Wendt; L A Augustine; S R Stecklein; E C Sibala; D Li; S Gunewardena; R A Jensen
Journal:  Oncogene       Date:  2014-11-24       Impact factor: 9.867

4.  Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.

Authors:  Matthias Dettmer; Aurel Perren; Holger Moch; Paul Komminoth; Yuri E Nikiforov; Marina N Nikiforova
Journal:  Thyroid       Date:  2013-09-19       Impact factor: 6.568

Review 5.  The complex genetic landscape of familial breast cancer.

Authors:  Lorenzo Melchor; Javier Benítez
Journal:  Hum Genet       Date:  2013-04-05       Impact factor: 4.132

Review 6.  Therapeutic microRNAs targeting the NF-kappa B signaling circuits of cancers.

Authors:  Lingying Tong; Ye Yuan; Shiyong Wu
Journal:  Adv Drug Deliv Rev       Date:  2014-09-16       Impact factor: 15.470

7.  miR-146a targets Fos expression in human cardiac cells.

Authors:  Xavier Palomer; Eva Capdevila-Busquets; Gaia Botteri; Mercy M Davidson; Cristina Rodríguez; José Martínez-González; Francisco Vidal; Emma Barroso; Tung O Chan; Arthur M Feldman; Manuel Vázquez-Carrera
Journal:  Dis Model Mech       Date:  2015-06-25       Impact factor: 5.758

8.  BRCA1 loss activates cathepsin L-mediated degradation of 53BP1 in breast cancer cells.

Authors:  David A Grotsky; Ignacio Gonzalez-Suarez; Anna Novell; Martin A Neumann; Sree C Yaddanapudi; Monica Croke; Montserrat Martinez-Alonso; Abena B Redwood; Sylvia Ortega-Martinez; Zhihui Feng; Enrique Lerma; Teresa Ramon y Cajal; Junran Zhang; Xavier Matias-Guiu; Adriana Dusso; Susana Gonzalo
Journal:  J Cell Biol       Date:  2013-01-21       Impact factor: 10.539

Review 9.  Regulation of breast cancer and bone metastasis by microRNAs.

Authors:  S Vimalraj; P J Miranda; B Ramyakrishna; N Selvamurugan
Journal:  Dis Markers       Date:  2013-09-26       Impact factor: 3.434

10.  Pathway analysis of microRNA expression profile during murine osteoclastogenesis.

Authors:  Tiziana Franceschetti; Neha S Dole; Catherine B Kessler; Sun-Kyeong Lee; Anne M Delany
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.